• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多巴胺能功能与帕金森病的进展:PET 研究结果。

Dopaminergic function and progression of Parkinson's disease: PET findings.

机构信息

Pacific Parkinson's Research Centre, University of British Columbia, Vancouver, Canada.

出版信息

Parkinsonism Relat Disord. 2009 Dec;15 Suppl 4:S38-40. doi: 10.1016/S1353-8020(09)70833-8.

DOI:10.1016/S1353-8020(09)70833-8
PMID:20123555
Abstract

Recent PET studies in Parkinson's disease (PD) have shown that the progression of neurodegeneration follows an exponential decay pattern. Most of the damage to the nigrostriatal dopamine system occurs during the presymptomatic phase of the disease and the first few years following symptom onset. The progressive loss of dopaminergic neurons is accompanied by several functional adaptive changes in surviving nerve terminals, which lead to increased dopamine turnover and raise the risk of treatment-related motor complications. Younger PD patients seem to have more efficient compensatory mechanisms and a slower rate of progression of neurodegeneration.

摘要

最近帕金森病(PD)的 PET 研究表明,神经退行性变的进展遵循指数衰减模式。黑质纹状体多巴胺系统的大部分损伤发生在疾病的无症状期和症状出现后的最初几年。多巴胺能神经元的进行性丧失伴随着存活神经末梢的几种功能适应性变化,这导致多巴胺周转率增加,并增加与治疗相关的运动并发症的风险。年轻的 PD 患者似乎有更有效的补偿机制和更慢的神经退行性变进展速度。

相似文献

1
Dopaminergic function and progression of Parkinson's disease: PET findings.多巴胺能功能与帕金森病的进展:PET 研究结果。
Parkinsonism Relat Disord. 2009 Dec;15 Suppl 4:S38-40. doi: 10.1016/S1353-8020(09)70833-8.
2
Imaging the nigrostriatal system to monitor disease progression and treatment-induced complications.对黑质纹状体系统进行成像,以监测疾病进展和治疗引起的并发症。
Prog Brain Res. 2010;184:177-92. doi: 10.1016/S0079-6123(10)84009-9.
3
PET studies of the striatal dopaminergic system in Parkinson's disease (PD).帕金森病(PD)纹状体多巴胺能系统的正电子发射断层扫描(PET)研究。
J Neural Transm Suppl. 1995;45:123-31.
4
Age-specific progression of nigrostriatal dysfunction in Parkinson's disease.帕金森病患者黑质纹状体功能的年龄特异性进展。
Ann Neurol. 2011 May;69(5):803-10. doi: 10.1002/ana.22284. Epub 2011 Jan 18.
5
Monitoring therapeutic effects in Parkinson's disease by serial imaging of the nigrostriatal dopaminergic pathway.通过连续的黑质纹状体多巴胺能通路成像监测帕金森病的治疗效果。
J Neurol Sci. 2011 Nov 15;310(1-2):40-3. doi: 10.1016/j.jns.2011.07.029. Epub 2011 Aug 15.
6
Axonal damage and loss of connectivity in nigrostriatal and mesolimbic dopamine pathways in early Parkinson's disease.早期帕金森病中黑质纹状体和中脑边缘多巴胺能通路的轴突损伤及连接丧失
Neuroimage Clin. 2017 Mar 27;14:734-740. doi: 10.1016/j.nicl.2017.03.011. eCollection 2017.
7
Cell type analysis of functional fetal dopamine cell suspension transplants in the striatum and substantia nigra of patients with Parkinson's disease.帕金森病患者纹状体和黑质中功能性胎儿多巴胺细胞悬浮移植的细胞类型分析
Brain. 2005 Jul;128(Pt 7):1498-510. doi: 10.1093/brain/awh510. Epub 2005 May 4.
8
PET and SPECT functional imaging studies in Parkinsonian syndromes: from the lesion to its consequences.帕金森综合征的正电子发射断层扫描(PET)和单光子发射计算机断层扫描(SPECT)功能成像研究:从病损到其后果
Neuroimage. 2004 Sep;23(1):1-16. doi: 10.1016/j.neuroimage.2004.04.039.
9
Nigrostriatal dopamine transporter availability in early Parkinson's disease.早期帕金森病患者黑质纹状体多巴胺转运体的可利用性。
Mov Disord. 2018 Apr;33(4):592-599. doi: 10.1002/mds.27316. Epub 2018 Feb 13.
10
Imaging beyond the striatonigral dopaminergic system in Parkinson's disease.帕金森病中纹状体黑质多巴胺能系统之外的成像研究
Hell J Nucl Med. 2012 Sep-Dec;15(3):224-32. doi: 10.1967/s002449910058. Epub 2012 Oct 25.

引用本文的文献

1
C-CFT PET brain imaging in Parkinson's disease using a total-body PET/CT scanner.使用全身正电子发射断层扫描/计算机断层扫描(PET/CT)扫描仪对帕金森病进行C-CFT正电子发射断层扫描(PET)脑成像。
EJNMMI Phys. 2024 Apr 25;11(1):40. doi: 10.1186/s40658-024-00640-4.
2
International consensus on clinical use of presynaptic dopaminergic positron emission tomography imaging in parkinsonism.帕金森病中突触前多巴胺正电子发射断层成像的临床应用国际共识。
Eur J Nucl Med Mol Imaging. 2024 Jan;51(2):434-442. doi: 10.1007/s00259-023-06403-0. Epub 2023 Oct 4.
3
Development and validation of a radiomic model for the diagnosis of dopaminergic denervation on [18F]FDOPA PET/CT.
基于[18F]FDOPA PET/CT 构建用于诊断多巴胺能神经纤维丧失的放射组学模型的建立与验证。
Eur J Nucl Med Mol Imaging. 2022 Sep;49(11):3787-3796. doi: 10.1007/s00259-022-05816-7. Epub 2022 May 14.
4
The sensitivity and specificity of F-DOPA PET in a movement disorder clinic.F-DOPA正电子发射断层扫描(PET)在运动障碍门诊的敏感性和特异性。
Am J Nucl Med Mol Imaging. 2016 Jan 28;6(1):102-9. eCollection 2016.
5
Paraquat and psychological stressor interactions as pertains to Parkinsonian co-morbidity.百草枯与心理应激源的相互作用与帕金森病合并症有关。
Neurobiol Stress. 2015 Nov 12;2:85-93. doi: 10.1016/j.ynstr.2015.09.001. eCollection 2015.
6
The diagnostic value of minor salivary gland biopsy in clinically diagnosed patients with Parkinson's disease: comparison with DAT PET scans.小唾液腺活检在临床诊断的帕金森病患者中的诊断价值:与多巴胺转运体正电子发射断层扫描(DAT PET)的比较
Neurol Sci. 2015 Sep;36(9):1575-80. doi: 10.1007/s10072-015-2190-5. Epub 2015 Mar 28.
7
How to design PET experiments to study neurochemistry: application to alcoholism.如何设计正电子发射断层扫描(PET)实验来研究神经化学:在酒精中毒研究中的应用
Yale J Biol Med. 2014 Mar 5;87(1):33-54. eCollection 2014 Mar.
8
Perspective: Identification of genetic variants associated with dopaminergic compensatory mechanisms in early Parkinson's disease.观点:鉴定与早期帕金森病多巴胺能代偿机制相关的遗传变异。
Front Neurosci. 2013 Apr 15;7:52. doi: 10.3389/fnins.2013.00052. eCollection 2013.
9
CSF and clinical hallmarks of subcortical dementias: focus on DLB and PDD.脑脊液和皮质下痴呆的临床特征:以 DLB 和 PDD 为重点。
J Neural Transm (Vienna). 2012 Jul;119(7):861-75. doi: 10.1007/s00702-012-0820-0. Epub 2012 May 24.